Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
administered, Affitech, announced, antitrypsin, brain, complimentary, COPD, COSO, debilitating, elapsed, enacted, endpoint, enticement, exploring, fatal, firm, forecasted, formulation, fraud, headcount, HGS, Idec, IND, Inhibitex, ischemia, join, laryngeal, led, Lev, neurocognitive, neuroprotective, ninety, observed, outlined, Paragraph, pegylated, pertain, pharmacology, profile, promulgated, proposed, Pulmozyme, quoted, refinanced, reliability, reperfusion, retrospective, slightly, statistical, suitable, Syntonix, Tanox, TOBI, toxicology, Track, Treadway, unauthorized, undistributed, unrealized, ZLB
Removed:
addressing, aimed, Alitalo, allocated, alternative, annualized, antidilutive, appeal, asserted, auditing, augment, BD, Becton, behalf, Bioscience, Circuit, coincident, collaborating, complaint, consumable, converted, desirable, Dickinson, District, Dr, favor, fourth, fringe, greatest, Helsinki, intercompany, inventory, invest, irrevocable, isolated, jurisdiction, Kari, multiplying, Nuclear, open, periodic, predetermined, purified, radioactive, ratable, replaced, serine, short, stable, stopping, throughput, ulcerative, unit, University, unrestricted, work, York
Filing tables
Filing exhibits
Related press release
DYAX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-113500) and Form S-8 (Nos. 333-119607, 333-105842, 333-49852, 333-49856, 333-97523, and 333-97527) of Dyax Corp. of our report dated March 1, 2005 relating to the financial statements, financial statement schedule, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP |
|
|
|
| |
Boston, Massachusetts |
| |
March 1, 2005 |
|